Related Experiment Videos
Effective terminal sterilization using supercritical carbon dioxide.
Angela White1, David Burns, Tim W Christensen
1NovaSterilis Inc., Lansing, NY 14882, USA.
Journal of Biotechnology
|February 25, 2006
Summary
A new supercritical carbon dioxide sterilization method rapidly inactivates bacterial endospores in packaging. This gentle process preserves microbial structure and protein profiles, suiting sensitive biomedical products.
Area of Science:
- Biomedical Engineering
- Microbiology
- Chemical Engineering
Background:
- Advances in biomedical technologies necessitate gentle sterilization alternatives.
- Supercritical fluid technologies, particularly supercritical CO(2), show promise for medical contaminant inactivation.
- Current supercritical CO(2) methods face challenges in rapidly inactivating bacterial endospores for terminal sterilization.
Purpose of the Study:
- To develop a supercritical CO(2) based sterilization process for rapid and gentle inactivation of bacterial endospores.
- To assess the suitability of this process for terminal sterilization of sensitive biomedical products.
Main Methods:
- Development of a novel supercritical CO(2) sterilization process.
- Evaluation of the process's efficacy in inactivating bacterial endospores within terminal packaging.
- Analysis of microbial morphology, ultrastructure, and protein profiles post-sterilization.
Main Results:
- The developed supercritical CO(2) process achieved rapid inactivation of bacterial endospores in terminal packaging.
- The sterilization method was found to be gentle, preserving the morphology, ultrastructure, and protein profiles of the inactivated microbes.
- The process demonstrated effectiveness without compromising the integrity of sensitive materials.
Conclusions:
- A gentle and effective supercritical CO(2) sterilization process has been developed for bacterial endospore inactivation.
- This technology is suitable for terminal sterilization of a wide range of sensitive biomedical products, including tissue-derived materials and protein-based therapies.